Literature DB >> 6361371

[Early detection of diabetic nephropathy: serum beta 2-microglobulin].

F D Goebel, T Schmeidl, H S Füessl, S Vogel.   

Abstract

Detection of early diabetic nephropathy is necessary to postpone or even prevent progression of irreversible kidney damage by therapeutic measures. Beta 2-microglobulin (beta 2-MG) as a parameter of the glomerular filtration rate has been measured by immunoassay in the serum of 100 diabetic subjects, 50 insulin-dependent (IDD), and 50 noninsulin-dependent (NIDD) patients. The results are compared with endogeneous creatinine-clearance, serum creatinine concentration, and proteinuria and are related to different stages of diabetic retinopathy (RD). Normal values were obtained from 50 healthy age- and sex-matched subjects. A close correlation was found between beta 2-MG levels and endogeneous creatinine clearance. Thirty-nine diabetics revealed an elevated beta 2-MG (2.5 mg/l or higher), only 16 of whom had increased serum creatinine levels (1.4 mg/dl or higher). Significant differences of beta 2-MG were obtained between each group of patients with different stages of RD. A relevant difference of serum creatinine was found only between patients with normal eye fundus and advanced proliferative retinopathy, respectively. Without RD 26% of the patients revealed elevated beta 2-MG but normal creatinine values demonstrating a "latent nephropathy", just 8% showed an increase of both parameters. Of the diabetics with proliferative retinopathy 40% suffered from impaired kidney function proven by reduced creatinine clearance and by elevation of beta 2-MG and creatinine as well, 15% just revealed an increase of beta 2-MG with normal creatinine levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361371     DOI: 10.1007/bf01537432

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

1.  Juvenile diabetes mellitus after forty years.

Authors:  A T Paz-Guevara; T H Hsu; P White
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

2.  Serum beta 2 microglobulin and its prognostic value in lymphomas.

Authors:  P L Amlot; M Adinolfi
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

3.  Serum 2 -microglobulin in renal disease.

Authors:  L Wibell; P E Evrin; I Berggård
Journal:  Nephron       Date:  1973       Impact factor: 2.847

4.  Serum 2 -microglobulin in various disorders.

Authors:  P E Evrin; L Wibell
Journal:  Clin Chim Acta       Date:  1973-01-24       Impact factor: 3.786

5.  Microalbuminuria to predict nephropathy in diabetics.

Authors:  L O Simpson
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

6.  Serum levels of beta-2-microglobulin--a new marker of activity in Crohn's disease.

Authors:  L Descos; C André; S Beorghia; C Vincent; J P Revillard
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

7.  Serum beta2-microglobulin in the assessment of renal function.

Authors:  R R Bailey; G W Tisch; S Pearson
Journal:  N Z Med J       Date:  1978-03-08

8.  Beta-2-microglobulin as renal diagnostic agent.

Authors:  V Braren; J Goddard; A B Brill; J J Touya
Journal:  Urology       Date:  1979-06       Impact factor: 2.649

9.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

Authors:  G C Viberti; J C Pickup; R J Jarrett; H Keen
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

10.  Antihypertensive treatment inhibiting the progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1980
View more
  1 in total

1.  [Changes in renal protein excretion and kidney function in type I diabetic patients during and following pregnancy in relation to the stage of preexistent diabetic nephropathy].

Authors:  G Biesenbach; W Stöger; J Zazgornik
Journal:  Klin Wochenschr       Date:  1987-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.